CytomX Therapeutics, Inc.

Nasdaq:CTMX

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/6/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

29 shown

Filed	Period
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
3/6/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
↓

News (8-K)

51 shown

Filed	Type	Description
8/13/25	Other	Other Events	→
6/13/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/28/25	Other	Other Events	→
5/13/25	Other	Other Events	→
2/26/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
2/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

38 shown

Filed	Form	Description
8/7/25	S-8	S-8	→
8/7/25	S-3	S-3	→
5/12/25	424B5	424B5	→
3/6/25	S-8	S-8	→
8/9/24	S-3	S-3	→
3/11/24	S-8	S-8	→
↓

Filing History(751 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Mar 4, 2026

0001907884-26-000006

—

9.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0000947871-26-000190

—

7.3 KB

SCHEDULE 13G/A

Feb 17, 2026

0001214659-26-002019

—

13.1 KB

SCHEDULE 13G/A

Feb 5, 2026

0000315066-26-000388

—

11.4 KB

Feb 4, 2026

0001610717-26-000043

Feb 2, 2026

9.5 KB

Feb 4, 2026

0001610717-26-000042

Feb 2, 2026

7.2 KB

Feb 4, 2026

0001610717-26-000041

Feb 2, 2026

7.2 KB

Feb 4, 2026

0001610717-26-000040

Feb 2, 2026

7.2 KB

Feb 4, 2026

0001610717-26-000039

Feb 2, 2026

8.1 KB

SCHEDULE 13G/A

Nov 14, 2025

0001738048-25-000016

—

17.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0000902664-25-005005

—

11.7 KB

SCHEDULE 13G/A

Nov 14, 2025

0001013594-25-001422

—

25.3 KB

Nov 10, 2025

0001610717-25-000372

Nov 6, 2025

5.9 KB

SCHEDULE 13G/A

Nov 7, 2025

0000315066-25-002911

—

11.4 KB

144

Nov 6, 2025

0001628280-25-050396

—

4.4 KB

8-K

Nov 6, 2025

0001193125-25-2695338-K

Nov 6, 2025

443.4 KB

10-Q

Nov 6, 2025

0001193125-25-26947710-Q

Sep 30, 2025

11.1 MB

SCHEDULE 13G/A

Nov 5, 2025

0000315066-25-002714

—

11.4 KB

Oct 29, 2025

0001610717-25-000370

Oct 20, 2025

5.4 KB

Oct 29, 2025

0001610717-25-000369

Oct 20, 2025

9.9 KB

Sep 30, 2025

0001610717-25-000357

Sep 26, 2025

7.6 KB

Sep 30, 2025

0001610717-25-000356

Sep 26, 2025

7.6 KB

Sep 30, 2025

0001610717-25-000355

Sep 26, 2025

7.6 KB

Sep 30, 2025

0001610717-25-000354

Sep 26, 2025

7.6 KB

SCHEDULE 13G

Aug 21, 2025

0000950170-25-110649

—

10.4 KB

25 filings shown

Filed	Form	Description
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
5/1/24	DEFA14A	DEFA14A	→
4/4/24	DEFA14A	DEFA14A	→
4/4/24	DEF 14A	DEF 14A	→
3/25/24	PRE 14A	PRE 14A	→
↓

CytomX Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(751 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
2/4/26	4	4	→
11/10/25	4	4	→
↓

Filed	Form	Description
3/4/26	SCHEDULE 13G	SCHEDULE 13G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓